WELL Health Technologies Corp. (TSE:WELL - Get Free Report)'s stock price fell 7.3% on Thursday . The company traded as low as C$3.78 and last traded at C$3.93. 880,969 shares were traded during trading, an increase of 5% from the average session volume of 837,068 shares. The stock had previously closed at C$4.24.
Analyst Upgrades and Downgrades
WELL has been the topic of several research analyst reports. CIBC cut shares of WELL Health Technologies from an "outperform" rating to a "neutral" rating and decreased their target price for the stock from C$5.50 to C$4.75 in a research report on Monday, January 22nd. Royal Bank of Canada set a C$5.50 target price on shares of WELL Health Technologies and gave the stock an "outperform" rating in a research report on Tuesday, February 6th. Finally, Pi Financial raised their target price on shares of WELL Health Technologies from C$8.25 to C$8.50 in a research report on Wednesday, January 31st. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of C$7.30.
View Our Latest Stock Report on WELL Health Technologies
WELL Health Technologies Stock Down 10.1 %
The firm has a market cap of C$914.86 million, a price-to-earnings ratio of -188.50, a P/E/G ratio of -1.93 and a beta of 1.27. The firm's fifty day moving average is C$3.91 and its two-hundred day moving average is C$3.98. The company has a debt-to-equity ratio of 49.27, a current ratio of 1.18 and a quick ratio of 1.02.
About WELL Health Technologies
(
Get Free Report)
WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers omni-channel healthcare services, including primary care and allied health clinic operations; gastrointestinal, and mental disorders; specialized care, including gastroenterology anesthesia services; diagnostic services related to cardiology, women's health, and bone/muscle health and cancer diagnostics; and telehealth services.
Recommended Stories
Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
